Karem Harth, MD
Specialty: Vascular Surgery
- Assistant Professor, CWRU School of Medicine
- Co-Director, Vascular Lab, UH St John Medical Center
Karem C. Harth, MD, MHS, RPVI, is a board-certified vascular surgeon and registered physician in vascular interpretation. She serves as Director of the Center for Comprehensive Venous Care and Co-Medical Director of Vascular Laboratories at University Hospitals Harrington Heart & Vascular Institute. In addition, she is an Assistant Professor of Surgery at Case Western Reserve University School of Medicine.
Dr. Harth earned her medical degree from the Stony Brook School of Medicine in New York. She also completed a Master of Health Science at Johns Hopkins Bloomberg School of Public Health. Dr. Harth then completed a general surgery residency and vascular surgery fellowship at University Hospitals Cleveland Medical Center.
Dr. Harth is an active member of multiple national professional organizations, including the Society for Vascular Surgery, American Venous Forum, Society for Vascular Ultrasound, American College of Surgeons and Society for Clinical Vascular Surgery (SCVS). She has given multiple lectures at regional, national and international society meetings.
Dr. Harth has been a contributing author on over 100 articles and abstracts in peer-reviewed journals and major societal meetings. She also serves as a manuscript reviewer for such highly regarded publications as Vascular and Endovascular Surgery, Journal of Vascular Surgery, Journal of Vascular Medicine, and Journal of Vascular Surgery: Venous and Lymphatic Disorders.
Dr. Harth treats a wide range of vascular diseases and is especially interested in the treatment of venous disease. She has earned research support related to chronic venous thrombosis, ventral hernia repair and vascular access techniques. She is a recipient of the Faculty Teaching Award in the Division of Vascular Surgery and Endovascular Therapies at UH Cleveland Medical Center and has been named multiple times as a Top Doctor by Cleveland Magazine.
- Pelvic Congestion Syndrome
- Vascular Surgery
- Venous Disease
- Vascular Surgery - American Board of Surgery
- Surgery - American Board of Surgery
Fellowship | Vascular Surgery
Vascular Surgery - Uh Case Medical Center (2013 - 2015)
Research Fellowship | General Surgery
General Surgery - Uh Case Medical Center (2008 - 2010)
Residency | General Surgery
General Surgery - Uh Case Medical Center (2006 - 2013)
Stony Brook University School Of Medicine (SUNY) (2002 - 2006)
Johns Hopkins Bloomberg School Of Public Health (2002)
University Of Rochester (1998)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Karem Harth did not disclose any Outside Relationships with Industry.